Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 1
2020 pubmed 2 citations

Does peri-implant bone loss affect the LL-37 and proteinase 3 levels in peri-implant sulcus fluid?

Turkoglu. Oya O; Efeoglu. Candan C; Atmaca. Harika H

Key Findings

  • Implants with peri‑implantitis had more peri‑implant sulcus fluid (PISF) than healthy implants
  • Total LL‑37 and proteinase 3 levels in PISF were unchanged regardless of inflammation
  • No correlation between pocket depth and LL‑37 or proteinase 3 levels

Practical Outcomes

  • For biohackers, this suggests that boosting LL‑37 isn’t likely to help prevent or treat implant‑related gum disease. Focus on proven oral hygiene practices and other anti‑inflammatory strategies rather than targeting this peptide for dental health.

Summary

The study looked at a natural antimicrobial peptide called LL‑37 and an enzyme that activates it in the fluid around dental implants. It found that while inflamed implants produce more fluid, the amount of LL‑37 and the enzyme didn’t change compared to healthy implants, and they weren’t linked to how deep the gum pockets were.

Abstract

Inactive human cathelicidin antimicrobial peptide is present in neutrophils, and proteinase 3 activates this peptide by producing active LL-37 peptide. LL-37 acts as a defensive peptide in the oral tissues. In the present study, the aim was to evaluate LL-37 and proteinase 3 levels in peri-implant sulcus fluid (PISF) in implants with and without peri-implantitis. Patients who simultaneously had dental implants with peri-implantitis and without peri-implantitis were included in the study. Forty-four samples with peri-implantitis and 34 samples without peri-implantitis from 16 patients were obtained. Intraoral evaluations such as pocket depth, modified sulcus bleeding index, and modified plaque index were noted. Enzyme-linked immunosorbent assay was used for the evaluation of PISF LL-37 and proteinase 3 levels. PISF volume was significantly increased in the implants with peri-implantitis than those without peri-implantitis (p < 0.05). No difference was present between PISF LL-37 and proteinase 3 total amounts between the implants with and without peri-implantitis (p > 0.05). Pocket depths and PISF LL-37 and proteinase 3 levels were not correlated in the groups (p > 0.05). PISF volume might be increased in response to peri-implant bone destruction. However, peri-implant tissue destruction caused by peri-implantitis does not seem to affect PISF LL-37 and proteinase 3 levels.

Study Information

Provider

pubmed

Year

2020

Date

2020-08-04T00:00:00.000Z

DOI

10.1186/s40729-020-00240-8

Citations

2

References

45